Teleflex Incorporated (NYSE:TFX) Shares Sold by Thompson Investment Management Inc.

Thompson Investment Management Inc. cut its stake in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 7.0% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,140 shares of the medical technology company’s stock after selling 160 shares during the period. Thompson Investment Management Inc.’s holdings in Teleflex were worth $518,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. First Horizon Advisors Inc. boosted its stake in shares of Teleflex by 60.0% in the fourth quarter. First Horizon Advisors Inc. now owns 128 shares of the medical technology company’s stock valued at $32,000 after purchasing an additional 48 shares during the period. Eagle Bay Advisors LLC purchased a new position in Teleflex in the 1st quarter valued at about $37,000. Cullen Frost Bankers Inc. acquired a new stake in shares of Teleflex during the first quarter valued at about $41,000. Carderock Capital Management Inc. purchased a new stake in shares of Teleflex during the first quarter worth about $49,000. Finally, Massmutual Trust Co. FSB ADV lifted its stake in shares of Teleflex by 526.5% in the first quarter. Massmutual Trust Co. FSB ADV now owns 213 shares of the medical technology company’s stock worth $54,000 after acquiring an additional 179 shares in the last quarter. 97.15% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have weighed in on TFX. Raymond James lowered their price objective on Teleflex from $272.00 to $255.00 and set an “outperform” rating for the company in a research note on Monday, August 7th. Stephens upped their price target on shares of Teleflex from $305.00 to $315.00 in a report on Thursday, July 27th. downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Thursday. Truist Financial dropped their target price on shares of Teleflex from $264.00 to $255.00 and set a “hold” rating for the company in a research report on Monday, August 7th. Finally, CL King started coverage on shares of Teleflex in a research report on Tuesday, May 30th. They set a “buy” rating and a $293.00 price target on the stock. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from, Teleflex has a consensus rating of “Hold” and a consensus target price of $268.92.

Read Our Latest Stock Analysis on TFX

Teleflex Trading Down 0.5 %

Shares of NYSE TFX opened at $213.45 on Friday. Teleflex Incorporated has a 12-month low of $182.65 and a 12-month high of $276.43. The company has a market cap of $10.03 billion, a price-to-earnings ratio of 27.40, a price-to-earnings-growth ratio of 2.28 and a beta of 1.03. The company has a current ratio of 2.60, a quick ratio of 1.47 and a debt-to-equity ratio of 0.35. The stock’s 50 day simple moving average is $230.51 and its 200 day simple moving average is $240.81.

Teleflex (NYSE:TFXGet Free Report) last posted its earnings results on Thursday, August 3rd. The medical technology company reported $3.41 EPS for the quarter, beating the consensus estimate of $3.21 by $0.20. The firm had revenue of $743.30 million for the quarter, compared to analysts’ expectations of $729.87 million. Teleflex had a return on equity of 15.48% and a net margin of 12.71%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the firm earned $3.39 EPS. Equities research analysts expect that Teleflex Incorporated will post 13.29 EPS for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Friday, September 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, September 14th. This represents a $1.36 annualized dividend and a yield of 0.64%. Teleflex’s dividend payout ratio is currently 17.46%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Want to see what other hedge funds are holding TFX? Visit to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with's FREE daily email newsletter.